欧盟发布2018/2019人畜共患病细菌的抗菌素耐药性报告_安全事件解读_专业解读_食品安全合规服务_食品伙伴罐�/title>

　　 食品伙伴网讯2021�?�?2日，欧盟食品安全局（EFSA）发�?018/2019人畜共患病细菌抗菌素耐药性（antimicrobial resistance ，AMR）的总结报告�

　　部分原文报道如下９�/div>

　　Data on antimicrobial resistance (AMR) in zoo notic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by the EFSA and the ECDC and reported in a yearly EU Summary Report. The annual mo nitoring of AMR in animals and food within the EU is targeted at seleced animal species correspo nding to the reporting year. The 2018 mo nitoring specifically focussed on poultry and their derived carcases/meat, while the mo nitoring performed in 2019 specifically focused on pigs and calves under 1 year of age, as well as their derived carcases/meat. Mo nitoring and reporting of AMR in 2018/2019 included data regarding Salmonella, Campylobacter and indicator Escherichia coli isolates, as well as data obtained from the specific mo nitoring of presumptive ESBL�?AmpC�?carbapenemase‐producing E. coli isolates. Additionally, some MSs reported voluntary data on the occurrence of meticillin‐resistant Staphylococcus aureus in animals and food, with some countries also providing data on antimicrobial susceptibility. This report provides an overview of the main findings of the 2018/2019 harmo nised AMR mo nitoring in the main food‐producing animal populations monitored, in related carcase/meat samples and in humans. wher available, data mo nitoring obtained from pigs, calves, broilers, laying hens and turkeys, as well as from carcase/meat samples and humans were combined and compared at the EU level, with particular emphasis on multidrug resistance, complete susceptibility and combined resistance patterns to critically im portant antimicrobials, as well as Salmo nella and E. coli isolates possessing ESBL�?AmpC�?carbapenemase phenotypes. The outcome indicators for AMR in food‐producing animals such as complete susceptibility to the harmo nised panel of antimicrobials in E. coli and the pre valence of ESBL�?AmpC‐producing E. coli have been also specifically analysed over the period 2015�C2019.

　　更多详情参见：https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2021.6490

　　本文由食品伙伴网食品资讯中心编辑，供网友参考，有任何疑问，请联系news@www.sqrdapp.com、�/span>

关键词： 欧盟食品安全局 EFSA 抗菌紟�/a> 细菌